Track Real Time Price

According to ChemAnalyst , The global market for Ivermectin Prices moved upward during the second quarter of 2026, although the intensity of the increase varied significantly across North America, Asia-Pacific (APAC), and Europe. Higher manufacturing expenses, elevated chemical feedstock costs, energy-price volatility, and changing pharmaceutical supply-chain conditions were the primary factors influencing the market. Ivermectin is a broad-spectrum antiparasitic pharmaceutical compound used in approved treatments for several parasitic infections in humans and animals. Consequently, its pricing is influenced by pharmaceutical manufacturing activity, raw-material availability, healthcare demand, regulatory conditions, and international trade flows. During Q2 2026, producers faced a challenging cost environment. In the United States, producer prices increased by 5.5% year-over-year in June, while China's PPI increased by 4.1%. Germany also recorded a 2.2% increase in producer prices ...

According to ChemAnalyst , The Ivermectin Prices experienced varied regional movements during the first quarter of 2026, reflecting differences in manufacturing costs, feedstock availability, veterinary demand, and macroeconomic conditions. While North America and Asia-Pacific registered price increases due to higher production costs and resilient demand, Europe recorded a decline as easing upstream costs and balanced inventories offset demand growth. Ivermectin remains one of the world's most widely used antiparasitic pharmaceutical ingredients, primarily utilized in veterinary medicine for livestock and companion animals while also serving selected pharmaceutical applications. Since the product relies on fermentation-based production, changes in agricultural feedstocks, energy prices, solvent costs, and manufacturing expenses significantly influence market pricing. North America Ivermectin Prices The Ivermectin Prices in North America strengthened throughout the first quarter o...

According to ChemAnalyst , The Ivermectin prices experienced varied movements across major global markets during the first quarter of 2026, reflecting differences in production costs, feedstock availability, pharmaceutical demand, and macroeconomic conditions. While North America and Asia-Pacific recorded upward price momentum due to rising manufacturing expenses and healthy demand, Europe observed a moderate decline as easing upstream costs and abundant raw material supply weighed on the market. As a widely used antiparasitic pharmaceutical ingredient in both human and veterinary medicine, Ivermectin remains influenced by fermentation feedstocks, solvent prices, energy costs, export activities, and livestock industry trends. Market participants closely monitored inflation, industrial production, and consumer demand indicators throughout the quarter to evaluate pricing direction and future procurement strategies. Ivermectin Prices in North America The North American Ivermectin market ...